EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and Blood–Brain Barrier Penetration of Nanovesicles Loaded with Cannabidiol

Lucia Grifoni, Elisa Landucci iD, Giuseppe Pieraccini iD, Costanza Mazzantini iD, Maria Camilla Bergonzi iD, Domenico E Pellegrini-Giampietro iD, Anna Rita Bilia iD

Pharmaceuticals · 25.01.2025 · 18 (2) · 160

DOI: 10.3390/ph18020160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 25.01.2025. Verfasst von Lucia Grifoni und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Chimica Ugo Schiff, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Firenze, Italy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of University and Research, #NEXTGENERATIONEU (NGEU), National Recovery and Resilience Plan (NRRP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cannabidiol (CBD) is a highly lipophilic compound with potential therapeutic applications in neurological disorders. However, its poor aqueous solubility and bioavailability, coupled with instability in physiological conditions, significantly limit its clinical use.

Objectives

This study aimed to develop and characterize nanovesicles incorporating Tween 20 to enhance CBD encapsulation, stability, and the performance across the blood–brain barrier (BBB).

Methods

Nanovesicles were prepared via thin-film hydration followed by sonication and optimized for size, polydispersity index, and zeta potential. Stability studies were conducted under physiological conditions and during storage at 4 °C. In vitro release studies employed the dialysis bag method, while permeability across the BBB was assessed using PAMPA-BBB and the hCMEC/D3-BBB cell line, characterized for brain endothelial phenotype and largely employed as a model of human blood–brain barrier (BBB) function. Cytotoxicity was evaluated via MTT and LDH assays.

Results

The quantification of CBD was carried out by HPLC-DAD and HPLC-MS/MS. Nanovesicles with Tween 20 (VS-CBD) exhibited smaller size (65.27 ± 1.27 nm vs. 90.7 ± 0.2), lower polydispersity (0.230 ± 0.005 vs. 0.295 ± 0.003), and higher stability compared to conventional liposomes (L-CBD). VS-CBD achieved high encapsulation efficiency (96.80 ± 0.96%) and recovery (99.89 ± 0.52%). Release studies showed sustained CBD release with Higuchi model fitting (R2 = 0.9901). Both PAMPA-BBB and hCMEC/D3-BBB cell lines demonstrated an improved controlled permeability of the formulation compared to free CBD. Cytotoxicity tests confirmed the good biocompatibility of VS-CBD formulations. The addition of Tween 20 to nanovesicles enhanced CBD encapsulation, stability, and controlled release.

Conclusions

These nanovesicles represent a promising strategy to improve CBD delivery to the brain, offering sustained therapeutic effects and reduced dosing frequency, potentially benefiting the treatment of neurological disorders.

Schlagwörter

Stichwörter der Autor:innen

Tween 20cannabidiolcontrolled releaseenhanced encapsulation and permeationhCMEC/D3 cell linenanovesiclesstability

Autor:innen und Institutionen

  • Dipartimento di Chimica Ugo Schiff, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Firenze, Italy.
  • Dipartimento di Scienze della Salute, University of Florence, Viale Pieraccini 6, 50139 Firenze, Italy.
  • Centro di Servizi di Spettrometria di Massa (CISM), University of Florence, Viale Pieraccini 6, 50139 Firenze, Italy.

ORCID-Profile: Elisa Landucci, Giuseppe Pieraccini, Costanza Mazzantini, Maria Camilla Bergonzi, Domenico E Pellegrini-Giampietro, Anna Rita Bilia

Förderung

  • Ministry of University and Research
  • #NEXTGENERATIONEU (NGEU)
  • National Recovery and Resilience Plan (NRRP)
  • MNESYS
  • Next Generation EU, in the context of the National Recovery and Resilience Plan, M4C2 Investment 1.4

Zitieren

APA

Grifoni, L., Landucci, E., Pieraccini, G., Mazzantini, C., Bergonzi, M. C., Pellegrini-Giampietro, D. E., & Bilia, A. R. (2025). Development and Blood–Brain Barrier Penetration of Nanovesicles Loaded with Cannabidiol. Pharmaceuticals, 18(2), 160. https://doi.org/10.3390/ph18020160

Vancouver

Grifoni L, Landucci E, Pieraccini G, Mazzantini C, Bergonzi MC, Pellegrini-Giampietro DE, et al. Development and Blood–Brain Barrier Penetration of Nanovesicles Loaded with Cannabidiol. Pharmaceuticals. 2025;18(2):160. doi:10.3390/ph18020160

BibTeX
@article{Grifoni2025,
  author = {Grifoni, Lucia and Landucci, Elisa and Pieraccini, Giuseppe and Mazzantini, Costanza and Bergonzi, Maria Camilla and Pellegrini-Giampietro, Domenico E and Bilia, Anna Rita},
  title = {Development and Blood–Brain Barrier Penetration of Nanovesicles Loaded with Cannabidiol},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {2},
  pages = {160},
  doi = {10.3390/ph18020160}
}
Kostenlos starten →